跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dalacin C - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dalacin C
Approved
STANDARD
Dalacin C
Pfizer Manufacturing Belgium NV
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
07555492c27ede81
Company
Pfizer Manufacturing Belgium NV
Type
Standard
Approval Details
Approval Id
07555492c27ede81
Drug Approval Philippines Name
Dalacin C
Product Name
Dalacin C
Registration Number
DRP-1952
Brand Name
Dalacin C
Generic Name
Clindamycin (as phosphate)
Dosage Form
Solution for Injection (IV/IM)
Dosage Strength
150 mg/mL (600mg/Ml)
Manufacturer
Pfizer Manufacturing Belgium NV
Importer
Pfizer, Inc.
Company Detail Path
/organization/pfizer-manufacturing-belgium
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
28 April 2024
Expiry Date
19 June 2029
Pharmacologic Category
Anti-infective (Lincosamide)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
07555492c27ede81
Type
Standard
Back to Philippines FDA Approvals